Mutant-specific BRAF and CD117 immunocytochemistry potentially facilitate risk stratification for papillary thyroid carcinoma in fine-needle aspiration biopsy specimens.

about

Mutant-specific BRAF and CD117 immunocytochemistry potentially facilitate risk stratification for papillary thyroid carcinoma in fine-needle aspiration biopsy specimens.

Item

http://www.wikidata.org/entity/Q48035282

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Mutant-specific BRAF and CD117 ...... e aspiration biopsy specimens.

@en

Mutant-specific BRAF and CD117 ...... e aspiration biopsy specimens.

@nl

type

Item

label

Mutant-specific BRAF and CD117 ...... e aspiration biopsy specimens.

@en

Mutant-specific BRAF and CD117 ...... e aspiration biopsy specimens.

@nl

prefLabel

Mutant-specific BRAF and CD117 ...... e aspiration biopsy specimens.

@en

Mutant-specific BRAF and CD117 ...... e aspiration biopsy specimens.

@nl

P1476

Mutant-specific BRAF and CD117 ...... e aspiration biopsy specimens.

@en

P2093

Huanwen Wu

http://www.w3.org/2001/XMLSchema#string

Jie Gao

http://www.w3.org/2001/XMLSchema#string

Junliang Lu

http://www.w3.org/2001/XMLSchema#string

Qingli Zhu

http://www.w3.org/2001/XMLSchema#string

Wenbo Li

http://www.w3.org/2001/XMLSchema#string

Yu Zhao

http://www.w3.org/2001/XMLSchema#string

Yufeng Luo

http://www.w3.org/2001/XMLSchema#string

Yuxin Jiang

http://www.w3.org/2001/XMLSchema#string

Zhilan Meng

http://www.w3.org/2001/XMLSchema#string

Zhiyong Liang

http://www.w3.org/2001/XMLSchema#string

P2860

Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody

Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology.

Immunohistochemistry with the anti-BRAF V600E (VE1) antibody: impact of pre-analytical conditions and concordance with DNA sequencing in colorectal and papillary thyroid carcinoma.

Identification of genes differentially expressed in benign versus malignant thyroid tumors

The Bethesda System For Reporting Thyroid Cytopathology.

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.

c-KIT receptor expression is strictly associated with the biological behaviour of thyroid nodules.

Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer.

Molecular testing of thyroid fine-needle aspirations improves presurgical diagnosis and supports the histologic identification of minimally invasive follicular thyroid carcinomas.

The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.

P2888

s13277-015-3837-9

P304

611-618

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-015-3837-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26240026

http://www.w3.org/2001/XMLSchema#string